TD Cowen analyst Dan Brennan lowered the firm’s price target on Bruker (BRKR) to $55 from $70 and keeps a Hold rating on the shares. The firm ...

Stifel lowered the firm’s price target on Bruker (BRKR) to $57 from $70 and keeps a Hold rating on the shares. Bruker continues to show ...

Scientific instrument company Bruker (NASDAQ:BRKR). reported Q4 CY2024 results exceeding the market’s revenue expectations, ...

Bruker Corporation BRKR delivered adjusted earnings per share (EPS) of 76 cents for the fourth quarter of 2024, up 8.6% year over year. The figure surpassed the Zacks Consensus Estimate by 1.3%. The ...

Discover key takeaways from Bruker Corporation's Q4 2024 earnings call, highlighting strong diagnostics, semiconductor growth, and confident 2025 ...

Bruker expects full-year earnings in the range of $2.67 to $2.72 per share, with revenue in the range of $3.47 billion to $3.54 billion. Bruker shares have fallen 12% since the beginning of the year.

Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended December 31, 2024. Frank H. Laukien, Bruker's ...

Bruker (NASDAQ:BRKR – Get Free Report) had its price target lowered by stock analysts at Barclays from $69.00 to $65.00 in a research note issued on Monday,Benzinga reports. The firm currently has an ...

Corporation reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of $0.76 against the forecast of $0.74. Revenue also exceeded projections, ...

Bruker Corporation today announced the launch of the VERTEX NEO Platform today with its first product, the VERTEX NEO R. This ...

Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before market opening on Thursday, February 13, 2025. The Company will host a ...